The American Society for Microbiology (ASM) welcomes a new President, President-Elect and new members of the Board of Directors. They begin serving their leadership terms on July 1, 2025. These leaders will play a pivotal role in advancing ASM’s strategic roadmap and overseeing the continued implementation of its 3 scientific units.
Alexander McAdam, M.D., Ph.D., the Director of Infectious Diseases Diagnostic Laboratory and associate professor of pathology at Harvard Medical School, will serve as the 2025-2026 ASM President.
Vaughn Cooper, Ph.D., professor of microbiology and molecular genetics and computational and systems biology at the University of Pittsburgh School of Medicine and Co-Founder and Director of the Center for Evolutionary Biology and Medicine, will serve as President-Elect of the Board of Directors.
In addition, Michael D. L. Johnson, Ph.D., has been elected to the Board of Directors as an At-Large Director. Michelle Dziejman, Ph.D., was appointed by the ASM Board of Directors, in accordance with ASM Bylaws, to serve the remainder of Cooper’s term as At-Large Director, which will conclude on June 30, 2026.
ASM congratulates its new and continuing leaders and looks forward to their contributions in advancing the microbial sciences and guiding the Society’s strategic vision.
